STOCK TITAN

Birchtech Reports Second Quarter 2026 Financial Results

(Moderate)
(Neutral)
Tags

Birchtech (NYSE American: BCHT) reported second quarter 2026 revenues of $3.8 million, up from $3.3 million a year earlier, driven mainly by higher air business demand, more extreme weather, higher natural gas prices, and initial water treatment sales. Gross profit remained at $1.0 million, with mix shift away from higher‑margin licensing revenues offsetting the revenue increase.

SG&A rose to $2.1 million and R&D to $0.6 million, while other expenses increased to $1.4 million, leading to a wider net loss of $3.0 million ($0.11/share) versus $1.5 million ($0.08/share). Adjusted EBITDA loss was $(1.9) million. Cash totaled $11.8 million with no debt at June 30, 2026, compared to $2.2 million at year‑end 2025.

All remaining IPR petitions against Birchtech’s SEA® mercury emissions patents were terminated, and a $78+ million patent infringement judgment remains outstanding on appeal, accruing post‑judgment interest. The company continued expanding its water business, advanced Carbon Rejuvenation capacity, and appointed Michael Mioska as CFO and Jim Trettel as COO.

Loading...
Loading translation...

Positive

  • Revenue growth to $3.8 million from $3.3 million year‑over‑year
  • Cash balance of $11.8 million and no debt as of June 30, 2026
  • All remaining IPR petitions against SEA® technology patents terminated
  • $78+ million patent infringement judgment remains outstanding and accruing interest
  • Initial water treatment sales in 2026 versus none in 2025

Negative

  • Net loss widened to $3.0 million from $1.5 million year‑over‑year
  • Adjusted EBITDA loss increased to $(1.9) million from $(1.0) million
  • SG&A expenses rose to $2.1 million from $1.7 million
  • Other expenses increased to $1.4 million from $0.4 million, including license and settlement fees
  • Shift away from higher‑margin licensing kept gross profit flat despite revenue growth

News Explained

At June 30, cash was $11.8 million with no debt; using first-quarter operating cash outflow of $2,206,853 as the comparison, that balance equals 601.5 days of cash use.

Sources and calculations
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $14,748,440 / ($2,206,853 / 90) = [object Object]

Market reaction after 2Q26 earnings report: BCHT -10.42% in the Aug 14 session

-10.42% 44.9x vol
8 alerts
-10.42% Session close to close
+9.6% Peak Tracked
-2.5% Trough Tracked
$37.04M Market Cap
44.9x Rel. Volume

In the Aug 14 session, BCHT declined 10.42%, reflecting a significant negative market reaction. Argus tracked a peak move of +9.6% during that session. Argus tracked a trough of -2.5% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. Trading volume was exceptionally heavy at 44.9x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -10.4% in the session following this news. Historical earnings event 1034021 produ...
Analysis

The stock dropped -10.4% in the session following this news. Historical earnings event 1034021 produced a 1.58% 24-hour reaction. Against this quarter’s larger net loss and Adjusted EBITDA loss, the platform record highlighted mixed earnings sensitivity; low short positioning did not add elevated short-interest risk.

Key Figures

Revenue: $3.8 million Gross profit: $1.0 million SG&A expenses: $2.1 million +5 more
8 metrics
Revenue $3.8 million Q2 2026 vs. $3.3 million in Q2 2025
Gross profit $1.0 million Q2 2026 vs. $1.0 million in Q2 2025
SG&A expenses $2.1 million Q2 2026 vs. $1.7 million in Q2 2025
Net loss $3.0 million Q2 2026 vs. $1.5 million in Q2 2025
Loss per share $0.11 per basic and diluted share Q2 2026 vs. $0.08 per share in Q2 2025
Adjusted EBITDA Loss of $1.9 million Three months ended June 30, 2026 vs. loss of $1.0 million in 2025
Cash $11.8 million As of June 30, 2026 vs. $2.2 million as of December 31, 2025
Patent judgment $78+ million Final judgment remains outstanding and is currently on appeal

Previous Earnings Reports

5 past events · Latest: May 13 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 13 Q1 earnings report Positive +17.2% Revenue growth, narrower loss, higher cash, and new water-treatment orders
Apr 29 Q1 earnings scheduling Neutral +6.1% Announcement of the upcoming first-quarter results and conference call
Mar 31 Q4 earnings report Positive +1.6% Patent judgment, uplisting, financing, and water-commercialization updates
Mar 24 Q4 earnings scheduling Neutral +0.0% Announcement of fourth-quarter results release and investor conference call
Nov 13 Q3 earnings report Positive +2.7% Revenue growth, profitability, licensing agreements, and water purchase orders

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings-tagged events had positive 24-hour reactions in all five records, averaging 5.51%, including two scheduling notices.

Key Terms

inter partes review, ptab, adjusted ebitda, non-gaap financial measure
4 terms
inter partes review regulatory
"attempts to challenge the Company’s patents under Inter Partes Review (IPR)"
An inter partes review is a formal proceeding at the U.S. Patent Office where a third party asks a panel to re-examine and possibly cancel all or part of an issued patent based on earlier public information. Investors care because the outcome can remove or uphold a company’s exclusive rights, directly affecting product exclusivity, potential revenue, legal exposure and the valuation of businesses that rely on that patent—like asking a neutral referee to re-check a key call in a game.
ptab regulatory
"petition filed with the Patent Trial and Appeal Board (PTAB)"
The PTAB is the Patent Trial and Appeal Board, a U.S. administrative body that reviews and decides challenges to the validity of issued patents—think of it as a referee or appeals court for patent rights. Its decisions can remove or confirm legal protections that give companies exclusive control over products or technologies, which matters to investors because those outcomes can sharply change a company’s future revenue prospects, competitive position, and legal risk.
adjusted ebitda financial
"Adjusted EBITDA totaled a loss of ($1.9) million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-gaap financial measure financial
"Adjusted EBITDA, a Non-GAAP financial measure"
A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Second Quarter 2026 Revenues of $3.8 Million; All Remaining IPR Petitions Challenging the Company’s Patents Terminated; Further Expansion of Water Business Underway

CORSICANA, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today reported financial results for the second quarter ended June 30, 2026.

Key Second Quarter 2026 & Subsequent Operational Highlights

  • Announced the end of all remaining attempts to challenge the Company’s patents under Inter Partes Review (IPR), with every petition filed with the Patent Trial and Appeal Board (PTAB) against Birchtech’s patented SEA® mercury emissions removal technology now dismissed, removed prior to institution, or resolved, and all parties previously involved permanently barred from bringing further patent validity challenges.
  • The Company's $78+ million final judgment in its patent infringement litigation remains outstanding, is currently on appeal, and continues to accrue post-judgment interest.
  • Appointed respected financial executive Michael Mioska, CPA, MBA, as Chief Financial Officer in May 2026, succeeding Fiona Fitzmaurice.
  • Promoted Jim Trettel to Chief Operating Officer; Mr. Trettel joined the Company in 2014, most recently served as Executive Vice President of Operations, and now oversees Birchtech’s corporate operations across both its clean air and clean water platforms.
  • Exhibited at leading industry and investor conferences, including the AWWA ACE26 Annual Conference & Exposition, the Pennsylvania Section AWWA Technical Conference, the ASMS 2026 Conference and the Noble Capital Markets Emerging Growth Conference.

Management Commentary

Richard MacPherson, Birchtech President and Chief Executive Officer, commented: “In our water business, we continued to execute on our ‘data-first’ strategy and put our platform in front of the industry at scale, showcasing our Design Center analytical services, RSSCT testing, SEA-IX™ nuclear-grade ion exchange resin line and granular activated carbon solutions at leading water industry conferences during the quarter, including AWWA ACE26 in Washington, D.C., the largest national gathering of water professionals. We continue to make meaningful progress towards establishing our Carbon Rejuvenation capacity and look forward to providing further updates to that end in the near-term.

“In addition, in June, the final remaining IPR petitions challenging our patents were terminated, ending failed attempts to invalidate our patented SEA® technology, with all parties previously involved permanently barred from bringing further validity challenges. With our patent estate secured, we are determined in our pursuit of the enforcement of the final judgment, approximately $78+ million, on which post-judgment interest continues to accrue. We are also committed to convert our licensed utilities into long-term product supply customers.

“We also strengthened our leadership team during the quarter, welcoming Michael Mioska as Chief Financial Officer in May and promoting Jim Trettel to Chief Operating Officer. Jim’s deep technical expertise and hands-on operational leadership have been instrumental in scaling both our air and water treatment platforms. With a strong balance sheet, a protected patent portfolio, and two complementary business lines reinforcing each other, Birchtech is well positioned to deliver sustained growth and long-term value for my fellow shareholders,” concluded MacPherson.

Second Quarter 2026 Financial Results

Revenues totaled $3.8 million in the second quarter of 2026, as compared to $3.3 million in the same year-ago quarter. The increase in revenues from the prior period was primarily due to increased air business demand driven by the mix of plants running combined with more extreme weather conditions, and higher natural gas prices in the current year compared to the prior year period. Additionally, sales were recognized for the water treatment market in 2026 compared to none in 2025.

Gross profit totaled $1.0 million as compared to $1.0 million in the same year-ago quarter. Gross profit was comparable to the prior period despite higher revenues as a result of a shift in revenues mix away from licensing revenues in 2025 which typically carry higher margins.

SG&A expenses totaled $2.1 million in the second quarter of 2026, as compared to $1.7 million in the same year-ago quarter. The increase in expenses was primarily due to increased professional fees driven by increased legal fees in 2026 and increased public company costs associated with the company’s uplisting to the NYSE American.

R&D expenses totaled $0.6 million in the second quarter of 2026, as compared to $0.5 million in the same year-ago quarter. R&D expenses relate to research conducted to develop water treatment products utilizing new sorbent technologies.

Other expenses totaled $1.4 million in the second quarter of 2026, as compared to $0.4 million in the same year-ago quarter. Other expenses consisted mainly of license and settlement fees and a loss on the change in the fair value of the profit share.

Net loss for the second quarter of 2026 totaled $3.0 million, or $0.11 per basic and diluted share, as compared to net loss of $1.5 million, or $0.08 per basic and diluted share, in the same year-ago quarter.

Adjusted EBITDA totaled a loss of ($1.9) million for the three months ended June 30, 2026, as compared to a loss of ($1.0) million during the three months ended June 30, 2025.

Cash as of June 30, 2026, totaled $11.8 million, with no debt, as compared to $2.2 million as of December 31, 2025.

Second Quarter 2026 Earnings Conference Call

Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, August 13, 2026, to discuss Birchtech's second quarter 2026 financial results and provide a corporate update. To participate, please use the following information:

Second Quarter 2026 Earnings Conference Call
Date: Thursday, August 13, 2026
Time: 5:00 p.m. Eastern time
U.S./Canada Dial-in: 1-877-407-0792
International Dial-in: 1-201-689-8263
Conference ID: 13761823
Webcast: BCHT Q2 2026 Earnings Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A telephone playback of the call will be available through Thursday, September 3, 2026. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 13761823. A webcast replay will be available for one year, using the webcast link above.

About Birchtech Corp.

Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) is a leader in specialty activated carbon technologies, delivering innovative solutions for air and water purification to support a cleaner, more sustainable future. The Company provides patented SEA® sorbent technologies for mercury emissions capture for the coal-fired utility sector and disruptive water purification technologies with a specialization on removing contaminants, including ‘forever chemicals’ such as PFAS, from potable water and industrial wastewater. Backed by a strong intellectual property portfolio and a team of activated carbon experts, Birchtech provides cleaner air to North American communities and is applying this expertise to a novel approach in water purification. To learn more, please visit www.birchtech.com.

Non-GAAP Financial Measures

To supplement our consolidated financial statements presented in accordance with GAAP and to provide investors with additional information regarding our financial results, we consider and are including herein Adjusted EBITDA, a Non-GAAP financial measure. We view Adjusted EBITDA as an operating performance measure and, as such, we believe that the GAAP financial measure most directly comparable to it is net income (loss). We define Adjusted EBITDA as net income adjusted for interest and financing fees, income taxes, depreciation, amortization, stock-based compensation, and other non-cash income and expenses. We believe that Adjusted EBITDA provides us an important measure of operating performance because it allows management, investors, debtholders and others to evaluate and compare ongoing operating results from period to period by removing the impact of our asset base, any asset disposals or impairments, stock-based compensation and other non-cash income and expense items associated with our reliance on issuing equity-linked debt securities to fund our working capital.

Our use of Adjusted EBITDA has limitations as an analytical tool, and this measure should not be considered in isolation or as a substitute for an analysis of our results as reported under GAAP, as the excluded items may have significant effects on our operating results and financial condition. Additionally, our measure of Adjusted EBITDA may differ from other companies’ measure of Adjusted EBITDA. When evaluating our performance, Adjusted EBITDA should be considered with other financial performance measures, including various cash flow metrics, net income and other GAAP results. In the future, we may disclose different non-GAAP financial measures in order to help our investors and others more meaningfully evaluate and compare our future results of operations to our previously reported results of operations.

The following table shows our reconciliation of net income (loss) to Adjusted EBITDA for the three months ended June 30, 2026, and 2025, respectively:

  For the Three Months Ended 
  June 30,  June 30, 
  2026  2025 
  (In thousands) 
       
Net income (loss) $(3,017) $(1,542)
         
Non-GAAP adjustments:        
Depreciation and amortization  110   105 
Change in fair value of profit share  258   377 
Contingent license and settlement fee  750   - 
Stock based compensation  -   20 
         
Adjusted EBITDA $(1,899) $(1,040)
         

Safe Harbor Statement

With the exception of historical information contained in this press release, content herein may contain “forward-looking statements” that are made pursuant to the Safe Harbor Provisions of the U.S. Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities laws (collectively, “forward-looking statements”). Forward-looking statements are generally identified by using words such as “anticipate,” “believe,” “plan,” “expect,” “intend,” “will,” and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. Forward-looking statements in this release include statements relating to expected developments and growth in Birchtech’s business. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. In addition, this release contains time-sensitive information that reflects management’s best analysis only as of the date of this release. Birchtech does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release. Further information concerning issues that could materially affect financial performance or other forward-looking statements contained in this release can be found in Birchtech’s periodic filings with the Securities and Exchange Commission or Canadian securities regulators.

Investor Relations Contact:

Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
BCHT@mzgroup.us
www.mzgroup.us


FAQ

How did Birchtech (BCHT) perform financially in Q2 2026?

Birchtech reported higher revenue but a larger net loss in Q2 2026. According to Birchtech, revenue reached $3.8 million versus $3.3 million a year earlier, while net loss widened to $3.0 million, or $0.11 per share, compared with $1.5 million, or $0.08 per share.

What were Birchtech's Q2 2026 revenues and Adjusted EBITDA (NYSE American: BCHT)?

Birchtech generated Q2 2026 revenues of $3.8 million and a negative Adjusted EBITDA. According to Birchtech, Adjusted EBITDA loss was $(1.9) million for the quarter, compared with a loss of $(1.0) million in the same period of 2025, reflecting higher operating and other expenses.

What is the status of Birchtech's patent IPR petitions and $78 million judgment in 2026?

All remaining IPR petitions challenging Birchtech’s SEA® patents have been terminated. According to Birchtech, every PTAB petition was dismissed, removed prior to institution, or resolved, and a roughly $78+ million patent infringement judgment remains outstanding on appeal, continuing to accrue post‑judgment interest.

What is Birchtech's cash and debt position as of June 30, 2026 (BCHT)?

Birchtech reported a stronger liquidity position with no debt. According to Birchtech, cash totaled $11.8 million as of June 30, 2026, up from $2.2 million at December 31, 2025, giving the company a net cash balance with no outstanding borrowings.

How did Birchtech's operating expenses change in Q2 2026?

Operating and related expenses increased in Q2 2026. According to Birchtech, SG&A expenses rose to $2.1 million from $1.7 million, R&D increased to $0.6 million from $0.5 million, and other expenses climbed to $1.4 million from $0.4 million versus the prior‑year quarter.

Who are Birchtech's new CFO and COO appointed in 2026 (BCHT)?

Birchtech updated its leadership team during 2026. According to Birchtech, Michael Mioska, CPA, MBA, was appointed Chief Financial Officer in May 2026, while long‑time executive Jim Trettel was promoted to Chief Operating Officer overseeing operations across the company’s clean air and clean water platforms.

How is Birchtech expanding its water business and Carbon Rejuvenation capacity?

Birchtech is advancing its water treatment platform and rejuvenation capabilities. According to Birchtech, the company showcased its Design Center services, SEA‑IX™ ion exchange resins, and granular activated carbon at major water conferences and continues making progress toward establishing Carbon Rejuvenation capacity, with further updates expected in the near term.